The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

QY Research Reports

SynopsisErwinia L-Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also .....

No Of Pages : 98
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00

SynopsisImatinib is a medication used to treat cancer. The global Gleevec market size is expected to reach US$ 595.2 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Gleevec in various e.....

No Of Pages : 74
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00

SynopsisImatinib is a medication used to treat cancer. The global Imatinib Mesylate Drugs market size is expected to reach US$ 595.2 million by 2029, growing at a CAGR of 8.5% from 2023 to 2029. The market is mainly driven by the significant applications of Imat.....

No Of Pages : 76
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00

SynopsisPonatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL). The global Ponatinib market size is expected to reach US$ .....

No Of Pages : 74
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00

SynopsisPonatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL). The global Ponatinib Drugs market size is expected to reac.....

No Of Pages : 72
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00

SynopsisIclusig is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL). The global Iclusig market size is expected to reach US$ 360.4 mill.....

No Of Pages : 77
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00

SynopsisMarqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration. The global Vincristine Sulfate Liposome Injection market size is expected to reach US$ 502.1 million by 20.....

No Of Pages : 70
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00

SynopsisMarqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration. The global Vincristine Sulfate Liposome Injection Drugs market size is expected to reach US$ 502.1 million.....

No Of Pages : 79
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00

SynopsisMarqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration. The global Marqibo market size is expected to reach US$ 351.2 million by 2029, growing at a CAGR of 6.9% f.....

No Of Pages : 78
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00

SynopsisPegaspargase is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. The global Pegaspargase market size is expected to reach US$ 505.9 million by 2029, growing at a CAGR of 8.2% from 2023 to 2.....

No Of Pages : 77
Publication Date: Mar, 2025
Single User Price : US$ 3,350.00